Submissions received by the Committee

Patent Amendment (Human Genes and Biological Materials) Bill 2010

Submissions received by the Committee

Sub No.

1Dr Charles Lawson  (PDF 535KB) 
2Clinical Associate Professor Judy Kirk (PDF 34KB) 
3Mr Adam Johnston  (PDF 187KB) Attachment 1(PDF 707KB) 
Supplementary Submission(PDF 19KB) 
4The Royal College of Pathologists of Australia (PDF 1170KB) 
5Human Genetics Society of Australasia (PDF 623KB) 
6Mr Christopher Aitchison (PDF 146KB) 
7Bayer CropScience (PDF 179KB) 
8Cancer Voices NSW (PDF 1969KB) 
9The Royal Australasian College of Physicians (RACP) (PDF 33KB) Attachment 1(PDF 67KB) 
10Mr Paul McCormack  (PDF 53KB) 
11Cancer Voices Australia (PDF 97KB) 
12Amgen Australia (PDF 665KB) 
13Perth Bone and Tissue Bank Inc. (PDF 37KB) 
14Abbott Australasia Pty Ltd (PDF 107KB) 
15South Australian Government (PDF 184KB) 
16Consumers Health Forum of Australia (PDF 460KB) 
17Davies Collison Cave (PDF 228KB) 
18Dr Ann Kurts, Dr Mark Lutherborrow and Professor Natalie Stoianoff (PDF 613KB) 
19Professor Andrew Christie (PDF 266KB) 
20Dr Malcolm Lyons (PDF 32KB) 
21Mr Doug Calhoun (PDF 176KB) 
Supplementary Submission(PDF 98KB) 
22Australian Medical Association (PDF 92KB) 
23SciVentures (PDF 88KB) 
24Peter MacCallum Cancer Centre (PDF 56KB) 
25Professor Peter Drahos  (PDF 34KB) 
26Liberty Victoria (PDF 93KB) 
27Australian Reproductive Health Alliance (PDF 77KB) 
28Group of Eight (PDF 2680KB) 
29Dr Hazel Moir (PDF 200KB) 
30Australian Law Reform Commission (PDF 950KB) Attachment 1(PDF 2112KB) 
31ChemSkill (PDF 275KB) 
32Sanofi Aventis (PDF 298KB) 
33National Coalition of Public Pathology (PDF 102KB) 
34Australian Institute for Innovation (PDF 3968KB) 
35International Federation of Intellectual Property Attorneys (FICPI) (PDF 546KB) 
36Foursight Associates (PDF 74KB) 
37Ms Stephanie Gleeson  (PDF 55KB) 
38Metabolic Pharmaceuticals (PDF 293KB) 
39Professor Dianne Nicol, Mr Johnathon Liddicoat, Dr Jane Nielsen and Mr Ben Mee (PDF 241KB) 
40Dr Chris Dent (PDF 429KB) 
41La Trobe University (PDF 189KB) 
42Roche (PDF 421KB) 
43Ms Elizabeth Gleeson (PDF 125KB) 
44St Vincent's Institute of Medical Research (PDF 66KB) 
45Grasslanz Technology Limited (PDF 1253KB) 
46National Health and Medical Research Council  (PDF 4625KB) 
47Griffith Hack and Griffith Hack Lawyers (PDF 3992KB) 
48Law Council of Australia (PDF 70KB) 
49The Institute of Patent and Trade Mark Attorneys of Australia (IPTA) (PDF 97KB) 
50Dr Teresa Schafer, Mr Tim Clark and Mr George Raitt (partners in Piper Alderman) (PDF 177KB) 
51Agrifood Awareness Australia  (PDF 46KB) 
52Eli Lilly Australia Pty Ltd (PDF 1336KB) 
53James and Wells Intellectual Property (PDF 159KB) 
54University of Western Sydney, University of Sydney, University of New South Wales, Macquarie University, University of Wollongong and Newcastle University (PDF 95KB) 
55Ms Anna George  (PDF 123KB) 
56CSL Limited (PDF 138KB) 
57IVD Australia Limited (PDF 951KB) 
58Hexima Limited (PDF 35KB) 
59Walter and Eliza Hall Institute of Medical Research (PDF 773KB) 
60Pfizer Australia (PDF 103KB) Attachment 1(PDF 1631KB) Attachment 2(PDF 646KB) 
61Dr Jennifer Leary (PDF 115KB) 
62Knowledge Commercialisation Australasia (KCA) (PDF 110KB) 
63Association of Australian Medical Research Institutes (PDF 152KB) 
64Garvan Institute of Medical Research (PDF 284KB) 
65CropLife Australia (PDF 348KB) 
66Sydnovate (PDF 789KB) 
67BioMelbourne Network (PDF 266KB) 
68Department of Health and Ageing (PDF 22KB) Attachment 1(PDF 48KB) 
Supplementary Submission(PDF 114KB) 
69GlaxoSmithKline Australia  (PDF 657KB) 
70Mylan Inc.  (PDF 2704KB) 
71Generic Medicines Industry Association (PDF 498KB) 
72Cancer Council Australia (PDF 324KB) 
73Prima BioMed Ltd (PDF 5206KB) Attachment 1(PDF 205KB) 
74Mr Geoffrey Burton (PDF 95KB) Attachment 1(PDF 228KB) Attachment 2(PDF 266KB) 
75Alphapharm Pty Limited  (PDF 70KB) 
76Merck Serono Australia (PDF 67KB) 
77FB Rice and Co (PDF 207KB) 
78CSIRO (PDF 62KB) 
79Mr Craig Patterson  (PDF 89KB) 
80ResMed Limited (PDF 331KB) 
81Genetic Technologies Limited (PDF 153KB) 
82Merck Sharp and Dohme (MSD) Australia (PDF 488KB) 
83Dr Mark Summerfield (PDF 47KB) 
Supplementary Submission(PDF 461KB) 
84Breast Cancer Action Group NSW (PDF 9KB) 
85Biomedical Consulting Services (PDF 161KB) 
86Biotechnology Industry Organization (PDF 102KB) 
87Shelston IP (PDF 129KB) 
88Murdoch Childrens Research Institute  (PDF 87KB) 
89Medicines Australia (PDF 228KB) 
90Grains Research and Development Corporation (GRDC)  (PDF 333KB) 
91Baxter Healthcare Pty Limited (PDF 31KB) 
92Professor Ian Frazer  (PDF 39KB) 
93Bristol-Myers Squibb Australia (PDF 955KB) 
94Department of Innovation, Industry, Science and Research and IP Australia  (PDF 200KB) Attachment 1(PDF 526KB) 
95Licensing Executives Society of Australia and New Zealand (LESANZ) (PDF 173KB) 
96Tasmanian Government (PDF 223KB) 
97AusBiotech Ltd (PDF 801KB) 
98Australian Academy of Technological Sciences and Engineering (PDF 508KB) 
99Mooroolbark Technology (PDF 235KB) 
100Australian Academy of Science (PDF 67KB) 
101Janssen, Pharmaceutical Companies of Johnson and Johnson (PDF 251KB) 
102Meat and Livestock Australia Limited (MLA)  (PDF 26KB) 
103Dr Luigi Palombi (PDF 883KB) 
Supplementary Submission(PDF 590KB) 
Supplementary Submission(PDF 327KB) 
104MS Research Australia (PDF 835KB) 
105Industry and Investment NSW (PDF 172KB) 
106Gene Ethics (PDF 326KB) 
107Confidential
108Confidential
109The Burnet Institute (PDF 190KB) 
110Amercian Intellectual Property Law Association (PDF 86KB) 
111Dr Warwick Neville FM, Dr Luigi Palombi, Dr Buddhima Lokuge (PDF 523KB) 
112Victorian Government (PDF 2303KB) 
113Ms Katrina Howard (PDF 113KB) Attachment 1(PDF 145KB) Attachment 2(PDF 140KB) 
114Genzyme Australasia (PDF 33KB) Attachment 1(PDF 1569KB) 
115Mr John Wood (PDF 45KB) 
116Ms Joanne Mulcahy (PDF 41KB) 
117Ms Lin Stuart (PDF 71KB) 
118Mrs Emily Wallis (PDF 221KB) 
119Ms Wilma Western (PDF 75KB) 
120Name Withheld (PDF 15KB) 
121Name Withheld (PDF 3KB) 
122Greenpeace Australia Pacific (PDF 634KB) Attachment 1(PDF 315KB) 


Additional Information Received

1Amendment to the Bill tabled by Senator the Hon Bill Heffernan on 28 April 2011(PDF 136KB) 
2Clarification of evidence provided by CropLife Australia on 31 May 2011(PDF 143KB) 
3Correspondence received from Government of Brazil on 8 June 2011(PDF 1255KB) 

Answers to Questions on Notice

1Response to question on notice provided by the Royal College of Pathologists of Australasia on 03 May 2011(PDF 57KB) 
2Response to questions on notice provided by Professor Dianne Nicol and Mr Johnathon Liddicoat on 12 May 2011(PDF 90KB) 
3Response to question on notice provided by Dr Luigi Palombi on 12 May 2011(PDF 96KB) 
4Response to questions on notice provided by CropLife Australia on 13 May 2011(PDF 149KB) 
5Response to questions on notice provided by the Walter and Eliza Hall Institute of Medical Research on 13 May 2011(PDF 142KB) 
6Response to question on notice provided by Medicines Australia on 17 May 2011(PDF 3035KB) 
7Response to questions on notice provided by the Generic Medicines Industry Association on 12 May 2011(PDF 812KB) 

For further information, contact:

Committee Secretary
Senate Legal and Constitutional Committees
PO Box 6100
Parliament House
Canberra ACT 2600
Australia

Phone:+61 2 6277 3560
Fax:+61 2 6277 5794
Email:legcon.sen@aph.gov.au